ITR Canada has significantly invested in highly trained chemists, state-of-the-art facilities and instrumentation to offer a comprehensive range of analytical services in compliance with FDA GLP requirements and the current ICH guidelines to support a full array of non-clinical and clinical (Phase I-III) services.

In addition, the analytical department offers analytical services to support inhalation toxicology studies that include determination of particle size distribution, analysis of inhalation mixtures for confirmation of aerosol homogeneity and concentration, and analysis of inhalation chamber atmospheres.

Drug stability and impurity tests
Analytical method development
Analysis of test article (TA) formulations
Analysis of aerosolized drugs
LC-MS-MS and/or HPLC bioanalysis of TA or drug metabolites in urine, plasma or serum

API 4000 Triple Quadrupole LC-MS-MS
HPLCs equipped with UV, PDA, fluorescence, radiometric and evaporative light scattering detection

Back to Our Services